Back to search
FDAFDA · Food and drugs·Recall number Z-1062-2014

Bausch & Lomb AKREOS AO Micro Incision Lens The Akreos IOL intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia secondary to the removal of a cataractous lens in adult patients.

Published February 26, 2014 · Recall initiated: October 16, 2013

Summary

FDA records medical device Class II recall Z-1062-2014, published February 26, 2014 and initiated October 16, 2013. Recalling firm: Bausch & Lomb Surgical, Inc.; Status: Terminated; Reported quantity: 336 IOLs (283 IOLs in the US, 53 IOLs outside the US); Lot: Model Numbers(s): AO60 and MI60L. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lens was manufactured with incorrect raw material.

What to do

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Bausch & Lomb Surgical, Inc.
Distributor
Worldwide Distribution: US (nationwide) and Internationally to: Great Britain, France, Spain, Portugal, Sweden, Russia and Guadeloupe.
Lot
Model Numbers(s): AO60 and MI60L
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Bausch & Lomb AKREOS AO Micro Incision Lens The Akreos IOL intended for primary implantation in the capsular bag of the eye for the visual correction of aphakia secondary to the removal of a cataractous lens in adult patients. recalled?

Yes. FDA published recall Z-1062-2014 on February 26, 2014. Reported hazard: Lens was manufactured with incorrect raw material.

What should I do if I have this product?

Voluntary: Firm initiated · Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit